连续局部布比卡因伤口输注减少脊髓脊膜膨出修复术后口服阿片类药物使用
结果显示,治疗组总阿片类药物用量及每日平均口服阿片用量均显著低于对照组,且更多患者术后未使用阿片类药物,疼痛评分无差异,治疗组出院更早。
要点
- 连续局部布比卡因伤口输注可减少开放性胎儿脊髓脊膜膨出修复术后阿片类药物用量
- 治疗组24%患者术后未使用阿片类药物,对照组仅4%
- 两组术后第1至4天疼痛评分无差异,治疗组出院更早
核心结论
- 连续局部布比卡因伤口输注可减少开放性胎儿脊髓脊膜膨出修复术后阿片类药物使用,且不增加疼痛评分。
主要发现
- 治疗组总阿片类药物用量(包括静脉剂量)为165 vs 52.5 mg(P=.001),每日平均口服阿片用量为30 vs 10.5 mg(P=.002),均低于对照组。
- 治疗组24%患者术后未使用阿片类药物,对照组为4%。
- 两组术后第1至4天疼痛评分、止吐药使用及肠道功能无差异,治疗组出院显著更早。
临床怎么用
- 对于接受开放性胎儿脊髓脊膜膨出修复术的孕妇,可考虑使用连续局部布比卡因伤口输注作为辅助镇痛方式,以减少术后阿片类药物用量。
局限性
- 本研究为回顾性单中心病历审查,样本量较小(共72例),可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For pregnancies complicated by fetal myelomeningocele who meet the established criteria, prenatal closure is a viable management option. Prenatal closure is an open procedure, with some techniques requiring greater dissection of maternal tissue than cesarean delivery; pain control is an important postoperative goal. Given the rising rates of opioid dependence and concerns regarding the fetal and neonatal effects of opioid use, our practice has turned to nonopioid pain management techniques. OBJECTIVE: This study aimed to compare postoperative opioid use and pain scores in women undergoing open fetal myelomeningocele repair with and without continuous local bupivacaine wound infusion. STUDY DESIGN: This was a retrospective, single-center chart review of all consecutive patients who underwent open myelomeningocele repair from March 2013 to December 2019. Women were enrolled at the time of referral and locally followed for 2 weeks postoperatively. The control group received patient-controlled epidural analgesia for 48 hours with acetaminophen and oral and intravenous opioids as needed. The treatment group received patient-controlled epidural analgesia for 24 hours with acetaminophen, oral and intravenous opioids, and continuous local bupivacaine infusion. Pain scores, medication use, and postoperative milestones and complications through discharge were abstracted from the chart and compared. RESULTS: Of 72 subjects, 51 were in the control group and 21 in the treatment group. Total opioid use, including intravenous doses (165 vs 52.5 mg; P=.001) and daily average oral opioid use (30 vs 10.5 mg; P=.002) were lower in the treatment group. In addition, 24% of women in the treatment group used no opioid postoperatively, compared with 4% in the control group. There was no difference in postoperative day 1 to 4 pain scores, antiemetic use, or bowel function; the treatment group was discharged significantly earlier. CONCLUSION: Postoperative opioid use was reduced in women who received continuous local wound infusion of bupivacaine for incisional pain control after prenatal myelomeningocele repair. Pain control is paramount following open myelomeningocele repair; local bupivacaine wound infusion is an important adjunct to reduce opioid use postoperatively.
引用
- Porter AC, Behrendt NJ, Zaretsky MV, et al. Continuous local bupivacaine wound infusion reduces oral opioid use for acute postoperative pain control following myelomeningocele repair. Am J Obstet Gynecol MFM. 2020. PMID: 33485023. doi:10.1016/j.ajogmf.2020.100296
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。